Patents Assigned to Idera Pharmacetuicals, Inc.
  • Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
    Patent number: 7329648
    Abstract: The invention provides methods for modulating the immune response caused by CpG-containing oligonucleotides. The methods according to the invention enable both decreasing the immunostimulatory effect for antisense applications, as well as increasing the immunostimulatory effect for immunotherapy applications.
    Type: Grant
    Filed: December 9, 2002
    Date of Patent: February 12, 2008
    Assignee: Idera Pharmacetuicals, Inc.
    Inventor: Sudhir Agrawal